Auraptene
CAS: 495-02-3
Ref. TM-T4115
5mg | 35,00 € | ||
10mg | 46,00 € | ||
25mg | 64,00 € | ||
50mg | 82,00 € | ||
100mg | 134,00 € | ||
500mg | 315,00 € | ||
1ml*10 (DMSO) | 54,00 € |
Informação sobre produto
- 7-geranyloxycoumarin
- (E)-7-Geranoxycoumarin
- 2H-1-Benzopyran-2-one, 7-((3,7-dimethyl-2,6-octadienyl)oxy)-, (E)-
- 2H-1-Benzopyran-2-one, 7-[[(2E)-3,7-dimethyl-2,6-octadienyl]oxy]-
- 2H-1-benzopyran-2-one, 7-[[(2E)-3,7-dimethyl-2,6-octadien-1-yl]oxy]-
- 7-Geranyloxycoumarin
- 7-[[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]oxy]-2H-1-benzopyran-2-one
- 7-{[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]oxy}-2H-chromen-2-on
- 7-{[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]oxy}-2H-chromen-2-one
- Aurapten
- Ver mais sinónimos
- Aurapten (C<sub>19</sub>H<sub>22</sub>O<sub>3</sub>)
- Coumarin, 7-(geranyloxy)-
- Coumarin, 7-[(3,7-dimethyl-2,6-octadienyl)oxy]-, (E)-
- Rapten
Auraptene is a coumarin derived from citrus plants that bears a geranyloxyl moiety at its C-7. It has anti-inflammatory, anti-carcinogenic, anti-bacterial, neuroprotective, and hepatoprotective activities. It inhibits leukocyte activation and induces phase II enzymes during the initiation phase of carcinogenesis.1 When examined for its potential use in Alzheimer's disease treatment, auraptene was shown to inhibit β-secretase (BACE1) activity with an IC50 value of 345.1 μM.
Propriedades químicas
Consulta técnica sobre: TM-T4115 Auraptene
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.